Pepti-drift: יצירת פפטידים בטוחים

תקציר מקורי באנגליתarXiv:2606.27824v3 Announce Type: replace Abstract: Therapeutic peptides are a promising drug modality, but their generation must satisfy multiple therapeutic constraints. We introduce BindSafe-PepBench, a fixed-budget benchmark that jointly evaluates target binding and four major safety metrics on the same generated candidates. We reveal that peptide length is a major confounder of joint binding-safety evaluation: longer peptides tend toward stronger predicted binding but less favorable predicted safety. This creates an apparent trade-off and can bias comparisons among models with different output-length distributions. We report absolute Safe-Active yield and exact-length-matched gains to distinguish generative improvements from output-length effects. High Safe-Active yield remains challe